Newsroom
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in the Washington Post. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19. Read story
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in Forbes. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read story
July 29, 2021
Loss of smell also observed in Argentine sample. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu DENVER, Colo. (July 29, 2021) — In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San […]
July 29, 2021
Dr. Fred Campbell, General and Hospital Medicine, was interviewed on this statewide public radio program and shared the latest recommendations for staying safe and healthy during the pandemic. Listen here
July 28, 2021
Dr. Fred Campbell, General and Hospital Medicine, was interviewed by KENS 5 for this story about the CDC’s latest mask recommendations. Watch story
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
